Literature DB >> 6201438

Hapten-specific B cell blockade of the immune response to a thymus-independent-1 antigen produced by concomitant administration of a thymus-independent-2 antigen.

H Snippe, A J Van Houte, J K Inman, E F Lizzio, B Merchant.   

Abstract

CBA/N mice harbour an X-linked B cell defect which is transmitted by CBA/N female mice to their hybrid male progeny. These mice mount normal responses to thymus-dependent (TD) and some thymus-independent (TI-1) antigens, while the response to TI-2 antigens is absent. Hapten-specific plaque-forming cell (PFC) responses to TD antigens can be blockaded by concomitant exposure of these mice to TI-2 antigens bearing the same hapten. This paper investigates in defective mice the blockade of their response to TNP3-LPS (trinitrophenylated lipopolysaccharide, a TI-1 antigen), imposed by DNP59-Ficoll (dinitrophenylated Ficoll, a TI-2 antigen). The effectiveness of the blocking agent, DNP59-Ficoll, differed in various inbred mouse strains: CBA/N X C3H/HeN F1 male greater than CBA/N female greater than CBA/N X C3H/HeN F1 female. The role of T cells in the observed hapten-specific blockade phenomenon was investigated using athymic CBA/N nude mice and a B cell tolerogen. Our findings indicate that T cell participation is not essential for the blockade of CBA/N PFC responses and they suggest that direct blockade of TI- and TD-responsive B cell populations is likely to occur.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201438      PMCID: PMC1454594     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Coupling of large haptens to proteins and cell surfaces: preparation of stable, optimally sensitized erythrocytes for hapten-specific, hemolytic plaque assays.

Authors:  J K Inman; B Merchant; L Claflin; S E Tacey
Journal:  Immunochemistry       Date:  1973-03

2.  Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235.

Authors:  F C McIntire; H W Sievert; G H Barlow; R A Finley; A Y Lee
Journal:  Biochemistry       Date:  1967-08       Impact factor: 3.162

3.  Synthesis of large haptenic compounds having a common functional group that permits covalent linkage to proteins, cell surfaces, and adsorbents.

Authors:  J K Inman; B Merchant; S E Tacey
Journal:  Immunochemistry       Date:  1973-03

4.  Structural and genetic basis of the in vivo immune response to TNP-LPS.

Authors:  D M Jacobs
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

5.  In vitro studies of the genetically determined unresponsiveness to thymus-independent antigens in CBA/N mice.

Authors:  P L Cohen; I Scher; D E Mosier
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

6.  B cell tolerance induced by polymeric antigens. III. Dissociation of antibody formation and memory generation in tolerant mice.

Authors:  G G Klaus; H N Willcox
Journal:  Eur J Immunol       Date:  1975-10       Impact factor: 5.532

7.  Thymus-independent antigens: the preparation of covalent, hapten-ficoll conjugates.

Authors:  J K Inman
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

8.  X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells.

Authors:  I Scher; A Ahmed; D M Strong; A D Steinberg; W E Paul
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

9.  X-linked B-lymphocyte defect in CBA/N mice. III. Abnormal development of B-lymphocyte populations defined by their density of surface immunoglobulin.

Authors:  I Scher; S O Sharrow; W E Paul
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

10.  Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness.

Authors:  D F Amsbaugh; C T Hansen; B Prescott; P W Stashak; D R Barthold; P J Baker
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.